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1. Introduction 
The venom of Naja nigricollis is a complex mix- 
ture of a variety of enzymes and polypeptide toxins. 
One of its most active principles is the cr-neurotoxin 
[ 1,2] , a polypeptide of 61 amino acids (M.W. = 
6787) with 4 disulfide bridges, which has been shown 
to act as a potent neuromuscular blocking agent [3]. 
This toxin, like cr-bungarotoxin [4,5 ] binds with a 
high selectivity, both in vivo and in vitro, to the 
cholinergic receptor protein integrated in an exci- 
table membrane or dispersed in solution [6]. Because 
of these exceptional properties, it was of primary 
interest to label the toxin with a radioactive isotope. 
Several neurotoxins with similar properties have 
been recently labeled with r3’ I [7,8] . In this letter 
we describe the tritiation of the a-neurotoxin from 
N. nigricollis. The principle of the method is first 
to iodinate the toxin and, subsequently, to replace 
iodine by tritium. Interestingly, in our experimental 
conditions, iodine does not react with tyrosyl resi- 
dues, as it does with other polypeptides [9, lo], but 
attacks a histidine side chain. The tritiated toxin has 
a specific radioactivity of 14,000 Ci per mole and 
exhibits all the properties of the native toxin. 
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2. Results and discussion 
2.1. Iodination 
0.88 pmole of ar-neurotoxin prepared according 
to [l] were dissolved in 0.8 ml of 0.1 M ammonium 
chloride ammonia buffer, pH 8.5. To the chilled so- 
lution 6 pmole of r*‘ICl in 150 ~1 methanol were 
added; after 30 set an excess of Na thiosulfate was 
added to destroy the unreacted iodine. The resulting 
solution was filtered on a Biogel P2 column (SO- 100 
mesh, 1 X 20 cm) prepared in 0.1 M acetic acid and 
the column was subsequently washed with 0.1 M 
acetic acid. The toxin passed unretained through 
the column, and thus was separated from the salts. 
0.85 pmole of peptide containing 0.65 patom iodine 
was recovered in acetic acid solution. Spectroscopic 
measurements did not show any shift of absorption 
in the tyrosine absorbing region at 280 run as com- 
pared to the native peptide, indicating no modifi- 
cation of the tyrosyl residue. 
2.2. Tritiation 
The acetic acid solution of toxin was evaporated 
and the dry iodopeptide dissolved in 0.5 ml 0.004 
M Na phosphate buffer pH 7.4 and placed in the spe- 
cial flask previously described [I 0] . The solution 
was frozen, and 10 mg of palladium-rhodium-alumina 
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Fig. 1. Binding of tritiated or-neurotoxin to excitable mem- 
brane fragments purified from homogenate of electric organ. 
Membrane fragments were purified by the method previously 
described [ 15 ] and added as a suspension in 0.7 M sucrose 
at the indicated concentration in the toxin solution. The 
toxin concentration was kept equal to 4.6 pmole per ml in 
a total volume of 0.5 ml containing: 1.6 X IO-' M NaCI, 
5 X 10e3 M KCI, 2 X lo-’ M MgC12, 2 X 10T3 M CaCla, 
3 X 10e4 M sodium phosphate pH 7.0 (physiological Ringer’s 
solution) and 0.35 M sucrose. The mixture of membranes 
and toxin was incubated for 45 min at room temperature 
and subsequently centrifuged in a Beckman Ultracentrifuge 
Model L with a rotor no. 30 at 30,000 rpm (approximately 
100,000 g) for 45 min at 4”. Aliquots of the supernatant 
were counted in a Packard Scintillation counter in Bray’s 
solution. The amount of radioactive toxin remaining in the 
supernatant was plotted as a function of the total amount 
of membrane added to the solution. 
catalyst (Engelhardt and Co) added. 10 Ci of pure 
tritium gas were then introduced, at a pressure of 
500 mm Hg. The mixture was brought to room tem- 
perature and shaken with the catalyst for 30 min 
at 25”. After removal of the tritium gas the sus- 
pension was poured on a Biorex 70 column (1 X 15 
cm, 4”) prepared in 0.05 M Na phosphate buffer, 
pH 7.2. Under these conditions the toxin adsorbs 
on the column. Labile tritium atoms were first re- 
moved by extensive washing (500 ml) of the column 
with phosphate buffer and the 3H toxin finally 
eluted by increasing the concentration of phosphate 
buffer up to 0.2 M. The column effluents were moni- 
tored with an LKB densitometer at 280 nm. Only 
one peak of UV absorbing material was eluted. This 
peak contained exclusively peptide-bound tritium 
and no iodine at all; the iodinated neurotoxin re- 
mained firmly bound to the Biorex resin. The spe- 
cific radioactivity of the tritiated material in each 
fraction of the peak was identical and equal to 14 
Ci per mmole. A total of 0.36 pmole of 3H labeled 
peptide was recovered in this experiment. The 
labeled toxin gave only one band at pH 4.5 .in poly- 
acrylamide gel electrophoresis performed according 
to Davis [ll]. 
The iodinated peptidic material submitted to the 
dehalogenation step contained 0.61 pmole iodo- 
toxin and 0.21 mole of unreacted toxin. Since the 
Biorex column separated the iodotoxin from the 
nonhalogenated peptide, the material recovered 
after dehalogenation should be made up of the un- 
reacted toxin (0.2 1 pmole) and of the tritiated pep- 
tide: by difference, 0.14 pmole. Since the specific 
radioactivity of tritium gas is 30 Ci per milliatom 
tritium, then the calculated radioactivity of the 
mixture of cold and labeled toxin should be approx- 
imately 12 Ci per mmole. This number is, indeed, 
very close to the 14 Ci per mmole found experimen- 
tally. This suggests that the sequence of events de- 
scribed is correct, and that the tritiation was carried 
out without dilution of the tritium gas by the hydro- 
gen of the solvent. As a consequence, the rate of his- 
tidine dehalogenation has to be more rapid than that 
of tritium-proton exchange. 
2.3. Identification of the labeled amino acid 
An aliquot of the 3H-labeled peptide was diluted 
with 1 mg of native a-neurotoxin and hydrolysed 
with 6 N HCl at 105” for 16 hr in a sealed vial. The 
amino acids obtained were separated in a Technicon 
analyser according to the procedure of Spackman et 
al. [ 121. About 10% of the calculated tritium atoms 
were recovered bound to histidine and only to this 
amino acid. This indicates that histidine was the 
amino acid labeled. The low yield of radioactivity 
recovered in this experiment is the consequence of 
an exchange between aromatic hydrogen and protons 
of the solvent promoted by the acid hydrolysis of 
the peptide. 
In the course of the iodination procedure no 
spectral shift at 280 nm occurred which means that 
in these conditions the tyrosyl residue did not react 
with iodine. If, however, the pH was raised to 11, 
then the spectrum changed: iodination of the tyrosyl 
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residue took place. Titration of the tyrosyl residue 
was completed only after several hours exposure 
to high pH. This suggests that in the native form 
of this toxin, like in the erubutoxin [8] or the co- 
brofoxin [7], the tyrosyl residue is buried inside the 
polypeptide chain [ 131. 
2.4. Biological tests 
The lethal activity of the tritiated toxin was 
assayed on mice as previously described [ 1 ] . The 
LDs,, of the tritiated toxin was 2.4 ccg and the LDloo 
3.35 pg, as compared to an LD5e of 1.7 pg and an 
LDr,-,,, of 2.0 pg for the native toxin. The immuno- 
reactivity of the labeled toxin was checked by im- 
muno-diffusion according to Ouchterlony [ 141 and 
was found to be identical to that of the native ma- 
terial: in addition, the precipitates of native o-toxin 
and of labeled toxin on the same preparation were 
coalescent. 
The curare-like action of the tritiated toxin was 
then assayed on the electroplax preparation from 
Electrophorus electricus. 1 I.cg/ml of either tritiated 
or native toxin gave approximately 80% blocking of 
the electrical response to 2.5 X 1 O-’ M carbamyl- 
choline [6] . As shown in the figure the tritiated 
toxin binds in vitro to excitable membrane frag- 
ments purified from homogenates of electric organ. 
The number of 3H-toxin binding sites was found to 
be 8.4 nmole/g protein. Assuming for AcChE a turn- 
over number of 750 mole of acetylcholine hydrolysed 
per hr and per g of protein and a M.W. per site of 
65,000, then we find that, in the membrane frag- 
ments, there are approximately 2.7 times more cata- 
lytic sites of AcChE than toxin binding sites. This 
result is in perfect agreement with previous findings 
with the native cY-neurotoxin [6]. The same figure 
indicates that in the presence of an excess of mem- 
brane fragments, approximately 90% of the tritiated 
toxin adsorbed. The contamination of the toxin pre- 
paration by non-binding tritiated material was thus 
less than 10%. Binding of the radioactive toxin to 
the membrane fragments was prevented by reversible 
and irreversible reagents specific for the cholinergic 
receptor site. The tritiated toxin had thus the same 
pharmacological and biochemical properties as the 
native toxin. 
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